Page 185 - 2023华南国际口腔展

enterprise at national level.This company is oriented to marine biomedical materials,
and prior develops hemostasis materials, trauma repair materials and tissue
engineering scaffold materials. Currently, company has obtained for more than 30
national invention patents and international invention patents.Currently the products
for sale are products for internal surgical hemostasis-SURCHI-fibre, for external
hemostasis-CHITOSAN HEMOSTATIC POWDER and CHITOSAN HEMOSTATIC
SPONGE, for promoting wound healing-HEMOSTATIC WOUND HEALING GAUZE
and Medical Gel Dressing.The dosage form involves different forms of powder and
fiber tablets etc.

和康生物科技股份有限公司
16.2KO8
MAXIGEN BIOTECH INC.

地址 /Address：上海市静安区裕通路 100 号宝矿洲际商务中心 8 楼
Address：Room 801, Intercontinental Business Center, No.100 Yutong Rd,
Jingan Dist, Shanghai, China
邮编 /Postal Code：200070
电话 /Tel：021-51029211
传真 /Fax：021-51028211
邮箱 /Email：Icey.Tan@mbi.com.tw
网址 /Website：https://mbi-bio.com/index.php?lan=cn

和康生物科技股份有限公司于 1998 年 12 月成立于台北，专注胶原蛋白研发工作。
2002 年逐渐发展出以生物高分子材料为主轴的核心技术应用于生物医材及医美化妆保
养品两大事业。和康公司拥有通过 ISO 22716 与 GMP 认证的工厂 , 受惠于生医研发
专业核心技术，结合了生医技术独家生产的胶原蛋白与玻尿酸，完整发展出抗老除皱、
低敏、保湿、美白等创新系列产品，对于肌肤的再生及修护具有更加功效。此外和康
与国际著名机构合作，引进优良技术开发并商品化，针对肌肤恢复年轻、弹性及光彩
不断研发创新更先进的技术和产品。
Maxigen Biotech Inc. (MBI) was founded in December 1998 and focus on R&D
work of collagen. MBI utilizes its core competence in biopolymers and has developed
a broad range of applications in areas such as medical devices and skincare
products. MBI's Biomedical facility is certified by GMP, ISO13485 and Korean KGMP.
Furthermore, it passed US FDA inspection in 2009 and 2015 with no significant
deviation being observed. MBI's biomedical products are mainly applied to the usage
of orthopedics, aesthetic medicine, dental and ophthalmology. Production quality
is in accordance with international regulations and requirements. Also our products
have been certified by China, USA, Europe, Southeast Asia, Middle East and other

123